MetaCap

Stevanato Group S.p.A. (STVN)

NYSE: STVNHealth CareMedical/Dental InstrumentsUSD

15.65-0.28 (-1.76%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

STVN stock chart

Technical analysis

Key statistics

All statistics
Dividend yield
0.39% ($0.00)
Ex-dividend date
Jun 11, 2026
52-week range
12.05 – 24.01
Day range
15.35 – 16.15
Volume / Avg
752.32K / 656.22K
Beta
—

52-week range

$12.05$24.01

STVN stock today

Stevanato Group S.p.A. (STVN) closed at $15.65 on Nov 20, down 1.76% (-$0.28), versus the S&P 500's 3.70% decline. Shares are 34.8% below their 52-week high of $24.01, set on Nov 25, 2025 and 29.9% above the 52-week low of $12.05, in the middle of the past year's range. STVN is down 22.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 30.1%.

At 26.5x trailing earnings, Stevanato Group S.p.A. trades below the peer-group median of 53.2x. Its forward P/E of 21.6x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Stevanato Group S.p.A.

Company profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.

Industry
Medical/Dental Instruments
CEO
Mr. Franco Stevanato
Headquarters
Piombino Dese, PD
Employees
6,010
IPO year
2021

Analyst forecast

Forecast

Consensus (13 analysts)

buy

Avg. price target

$19.46+24.35%

  • Strong buy 3
  • Buy 6
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $16.00High $25.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 3, 2026
EPS actual vs est.
$0.16 vs $0.17
Surprise
-5.88%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$0.062
Ex-dividend date
Jun 11, 2026

STVN news

All STVN news

Stevanato Group S.p.A. peers

Health Care sector
STVN peer companies
CompanyPrice% ChgMarket capCompare
ICUIICU Medical Inc.172.52-1.84%$4.31Bvs STVN
MMEDMiniMed Group Inc.16.01-1.54%$4.50Bvs STVN
HTFLHeartflow Inc.46.69+4.62%$4.10Bvs STVN
NVSTEnvista Holdings Corporation22.91-1.55%$3.67Bvs STVN
MMSIMerit Medical Systems Inc.84.34-0.08%$5.05Bvs STVN
PLSEPulse Biosciences Inc45.55+2.57%$3.35Bvs STVN
HAEHaemonetics Corporation120.16-0.17%$5.47Bvs STVN
IRTCiRhythm Holdings Inc.94.72+0.51%$3.18Bvs STVN

Indexes, lists and sector

Stevanato Group S.p.A. stock FAQ

What is Stevanato Group S.p.A.'s stock price today?

STVN last traded at $15.65 as of Nov 20, 4:00 PM EST, down 1.76% on the day. Prices are delayed at least 15 minutes.

Does Stevanato Group S.p.A. pay a dividend?

Yes. Stevanato Group S.p.A. pays $0.00 per share annually, a 0.39% yield. The most recent dividend of $0.062 had an ex-dividend date of Jun 11, 2026.

What is STVN's P/E ratio?

STVN trades at a trailing P/E ratio of 26.53 and a forward P/E of 21.62, compared with a median of 53.2 for its closest peers.

Who is Stevanato Group S.p.A.'s CEO?

Mr. Franco Stevanato is the chief executive officer of Stevanato Group S.p.A., which has about 6,010 employees.

What is the STVN 52-week high?

The 52-week high for STVN is $24.01 and the 52-week low is $12.05. The stock is currently 34.8% below its high.

Compare STVN